Key highlights
Explore more statements
Filter
Topics
Period
Filter by
recent search
Showing: 1 – 05 of 2 Media Statements

24 April 2023
Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges
Ipsen is committed to bringing innovative medicines to the rare disease community where a significant unmet need exists and innovation in treatments is lacking.

20 February 2023
Offering support to those impacted in Turkey & Syria
We are deeply saddened by the tragic earthquake across Turkey and Syria and the worsening humanitarian crisis. Our thoughts are with all of those impacted by the devastating events and our gratitude to those who are bravely leading the rescue efforts.
Your dedicated contacts
-
Amy Wolf
Vice President, Corporate Brand Strategy and Communications
-
Ioana Piscociu
Senior Manager, Media Relations
Related links